Takeda, Merck invest in Waltham cancer startup's $100M round
March 02, 2020 at 07:02 AM EST
A cancer biotech backed by Atlas Venture and F-Prime Capital has drawn the attention of some of the biggest names in oncology drugs and tripled its cash in a new financing round.
